Historically, the expression of two prognostic and predictive markers, oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2), has classified breast cancer (BC) into three distinct, non-overlapping subtypes: ER-positive/HER2-negative, HER2-positive and triple negative. The gene discussed is ERBB2; the disease is breast cancer.